CAS: 77-49-6; 2-Methyl-2-Nitro-1,3-Propanediol

该化合物是有机化合物,其结构中既有硝基化合物,也有氢氧基化合物,在室内温度下无色可粉黄,在水和各种有机溶剂中可溶解;该化合物具有三碳脊椎,有甲基组和与第二碳相连的硝基化合物,以及第一和第二碳的氢氧基组;这一配置有助于其再活动,使其在各种化学应用中有用,包括作为有机合成的中间体;该硝基化合物的存在具有某些电子医学特性,而氢基组则可以参与氢的结合,影响其溶解性和与其他物质的互动;安全数据表明,应当谨慎处理,因为它可能会对接触健康造成危害.

结构式图片

相似化合物

115-69-5 126-11-4 594-70-7

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号50-00-0 甲醛 | CAS号79-24-3 硝基乙烷 | CAS号71481-64-6 methanol with f... | CAS号25245-58-3 2-甲基-1,2,3-丙三醇 | CAS号24395-58-2 2-(hydroxyamino... | CAS号6270-16-2 3-硝基-2-丁醇,异构体混合物 | CAS号76-39-1 2-甲基-2-硝基-1-丙醇 | CAS号10359-57-6 4-Methyl-4-nitr... | CAS号115-69-5 2-氨基-2-甲基-1,3-丙... | CAS号17144-55-7 1,3-Dioxane,2-(... | CAS号1194-36-1 1,3-Dioxane,5-m... | CAS号65102-43-4 N-(1,3-dihydrox... | CAS号875-09-2 3,5-dimethyl-5-...

合成工艺路线路线简述

  • 合成目标产物 2-Methyl-2-Nitro-1,3-Propanediol 主要起始原料 Formaldehyde And Nitroethane
  • (文献来源)合成步骤主要原料 Formaldehyde 和 Nitroethane
聚合甲醛,硝基乙烷置于sodium Carbonate体系中,用 水 作为反应溶剂,化学反应 0.5H,以88.9%的收率获得产物2-硝基-2-甲基-1,3-丙二醇
参考文献:二(2-叠氮乙酸)-2'-甲基-2'-硝基-1',3'-丙 二酯及其制备方法
标题:二(2-叠氮乙酸)-2'-甲基-2'-硝基-1',3'-丙 二酯及其制备方法
摘要:本发明公开了一种二(2-叠氮乙酸)-2'-甲基-2'-硝基-1',3'-丙二酯,其结构式如(I)所示:本发明所涉及的化合物属于含能增塑剂,具有热稳定性较好,感度较低等特点,主要用于固体推进剂,发射药等领域.

海关参考信息

专利信息


专利号:US-8304409-B2
优先权日:2002-07-03
标 题:Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
发明人:EARL RICHARD A; EZAWA MAIKO; FANG XINQIN; GARVEY DAVID S; GASTON RICKY D; KHANAPURE SUBHASH P; LETTS L GORDON; LIN CHIA-EN; RANATUNGE RAMANI R; RICHARDSON STEWART K; SCHROEDER JOSEPH D; STEVENSON CHERI A; WEY SHIOW-JYI
权利人:EARL RICHARD A; EZAWA MAIKO; FANG XINQIN; GARVEY DAVID S; GASTON RICKY D; KHANAPURE SUBHASH P; LETTS L GORDON; LIN CHIA-EN; RANATUNGE RAMANI R; RICHARDSON STEWART K; SCHROEDER JOSEPH D; STEVENSON CHERI A; WEY SHIOW-JYI; NICOX SA
摘要:The invention describes novel nitrosated nonsteroidal antiinflammatory drugs (NSAIDs) and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated NSAID, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one nitrosated NSAID, and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one nitrosated NSAID, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating inflammation, pain and fever; for treating gastrointestinal disorders; for facilitating wound healing; for treating and/or preventing gastrointestinal, renal and/or respiratory toxicities resulting from the use of nonsteroidal antiinflammatory compounds; for treating inflammatory disease states and/or disorders; and for treating and/or preventing ophthalmic diseases and/or disorders.

专利号:US-9670134-B2
优先权日:2013-03-28
标 题:Synthesis of (2-nitro)alkyl (meth)acrylates via transesterification of (meth)acrylate esters
发明人:SATHIOSATHAM MUHUNTHAN; WILCZYNSKI ROBERT
权利人:ANGUS CHEMICAL
摘要:Provided is a process for making (2-nitro)alkyl (meth)acrylate compounds of formula I: wherein n, R, R 1 , R 2 , R 3 , R 4 , R 6 , R 7 , and n are as defined herein, by a transesterification reaction between a nitroalcohol compound and a (meth)acrylate compound in the presence of a transesterification catalyst and a free radical inhibitor.

专利号:DE-112014001664-T5
优先权日:2013-03-28
标题:Synthesis of (2-nitro) alkyl (meth) acrylates by transesterification of (meth) acrylate esters

专利号:US-2016046558-A1
优先权日:2013-03-28
标题 :Synthesis of (2-nitro)alkyl (meth)acrylates via transesterification of (meth)acrylate esters

专利号:WO-2014158445-A1
优先权日:2013-03-28
标 题 :Synthesis of (2-nitro)alkyl (meth)acrylates via transesterification of (meth)acrylate esters
枫霞泉(上海)科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.fengxiaquan.com
企业联系电话:18721743927👤
📞枫霞泉(上海)科技有限公司 ⚠️参考联系方式
联系人:张女士
电话:18721743927
手机:18721743927

邮箱:sales@fengxiaquan.com,rosezhangsales@126.com
通信地址: 上海市奉贤区奉金路559号2幢
邮编:
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海市奉贤区奉金路559号2幢
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1007/s13361-015-1253-4
摘要:Trimpin S. "Magic" Ionization Mass Spectrometry. Journal of The American Society for Mass Spectrometry. 2015 Oct 20;27(1):4–21. doi: 10.1007/s13361-015-1253-4.
摘要:Journal of Industrial Hygiene and Toxicology., 22(315), 1940
摘要:Journal of Pharmacology and Experimental Therapeutics., 93(26), 1948
摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
摘要:Khimiko-Farmatsevticheskii Zhurnal. Chemical Pharmaceutical Journal. For English translation, see PCJOAU., 11(1)(73), 1977
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知